Centauri Therapeutics starting with £24m financing Antimicrobial resistance specialist Centauri Therapeutics Ltd has closed a £24m Series A round to identify novel therapeutic candidates using the Alphamer technology. more ➔
Curve Therapeutics in US$1.7bn deal with MSDCurve Therapeutics has inked a contract with US pharma giant Merck & Co. (MSD) to screen novel small molecule drug candidates against five MSD targets. more ➔
Newton Biocapital launches new NBC III fundNewton Biocapital has launched a new life sciences fund with initial capital commitments of €50m and a target size of €150m. more ➔
New funds to boost European life sciences European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris. more ➔
Aicuris licences antisense RNA know-how from Hybridize TherapeuticsAiCuris will pay up to €100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients. more ➔
BioNTech collaborates with AGC BiologicsAGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription. more ➔
EU Council confirms European Scale-up InitiativeEU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies. more ➔
Protix raises €50m for expansionDutch insect protein specialist Protix has raised €50m for expansion and development from international investors and the ECBF. more ➔
Viennese Ribbon Biolabs closes €18m Series A financingRibbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures more ➔
mRNA specalist Ethris raises $26m in Series B financingGerman mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital. more ➔
